Neurocrine Biosciences Officer Eric Benevich Files Form 144 for $334K Planned Share Sale
NEUROCRINE BIOSCIENCES INC
Subscribe to track NBIX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📢 Form 144 Notice of Proposed Sale Company: Neurocrine Biosciences Inc ($NBIX) Insider: Eric Benevich (Officer) Shares to Sell: 2,154 Common Shares Approx. Value: $334,150.02 (~$155.13/share) Acquisition Method: Exercise of Stock Options Plan Date: June 10, 2026 (10b5-1 Plan) Broker: Morgan Stanley Smith Barney LLC
Comprehensive Analysis
Executive Summary
On September 9, 2026, Eric Benevich, an Officer at Neurocrine Biosciences, Inc. (CIK: 0000914475), filed a Form 144 notice for the proposed sale of 2,154 shares of Common Stock through Morgan Stanley Smith Barney LLC. The total aggregate market value of the proposed transaction is approximately $334,150.02.
Transaction & Plan Details
- Securities to be Sold: 2,154 shares of common stock acquired on September 9, 2026, via cash exercise of stock options.
- Pre-Arranged Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2026.
- Past 3-Month Activity: No other sales reported in the previous 3 months.
Market Impact & Significance
The filing indicates a standard option exercise and sale pursuant to a pre-established Rule 10b5-1 trading plan. The transaction represents a minimal portion of the issuer's 101,649,181 outstanding shares, suggesting low trading significance and routine liquidity planning.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.